For the first time, University of Minnesota scientists will be barred from accepting consulting fees from companies that sponsor their research, under a new ethics plan endorsed Friday by the Board of Regents.
President Eric Kaler says the new rule, which is designed to guard against conflicts of interest, is one of the strictest in the country among academic research centers.
The regents unanimously endorsed the 75-page plan, which recommends a series of changes to tighten safeguards for patients who volunteer in university research trials.
The plan was commissioned in the wake of widespread criticism of research practices at the U's psychiatry department and its handling of a 2004 drug study during which a 27-year-old patient, Dan Markingson, committed suicide.
Dr. William Tremaine of the Mayo Clinic, who led the task force that drafted the plan, said that one of the goals is to ensure that vulnerable patients like Markingson, who had schizophrenia, "know what they're getting into" and aren't coerced into studies.
"That's been a huge concern at the university over the last 11 years," Tremaine said Thursday, as he briefed the regents on the proposals.
The plan calls for beefing up scrutiny of research involving patients, and paying experts to serve on oversight panels.
It also takes a harder line on potential conflicts of interest. In the past, U scientists were permitted to do research for drug companies while serving as their paid consultants at the same time.